<p>Faraday Future: FF and Nasdaq-listed company Qualigen Therapeutics, Inc. announced today that they have signed a securities purchase agreement, whereby FF will invest in QLGN's common and preferred stock through a private placement, and will fully cooperate to develop cryptocurrency and Web3 business. After completing the shareholder approval process, QLGN will be renamed CXC10, fully focusing on the &#34;three-horse carriage&#34; business of cryptocurrency and Web3 ecosystem construction</p>

FFIE

<p>Faraday Future: FF and Nasdaq-listed company Qualigen Therapeutics, Inc. today jointly announced that they have signed a securities purchase agreement, under which FF will invest in QLGN's common and preferred stock through a private placement, and will fully cooperate to develop cryptocurrency and Web3 business. After completing the shareholder approval process, QLGN will be renamed CXC10, fully focusing on the "three pillars" of cryptocurrency business and Web3 ecosystem construction</p>

News